alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the amended Annual Report of Ambassadors International, Inc. (the Company) on Form 10-K/A for the year ended December 31, 2006 as
filed with the Securities and Exchange Commission on the date hereof (the Report), the undersigned, Brian R. Schaefgen, Chief Financial Officer of the Company certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that:



| | (1) | The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
| | --- | -------------------------------------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------



|                        |  | 
|----------------------- |  | 
|/s/ Brian R. Schaefgen  |  | 
|Brian R. Schaefgen      |  | 
|Chief Financial Officer |  | 
|May 9, 2007             |  | 

The foregoing certification is being furnished solely to accompany this Report pursuant to 18 U.S.C.
§1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof,
regardless of any general incorporation language in such filing.
§ 640.68 Processing. ( a ) *Sterile system.* All administration and transfer sets inserted into blood containers used for processing Source Plasma intended for manufacturing into injectable or noninjectable products and all interior surfaces of plasma containers used for processing Source Plasma intended for manufacturing into injectable products shall be sterile, pyrogen-free, nontoxic, and compatible with the contents under normal conditions of use. Only Sodium Chloride Injection USP shall be used as a red blood cell diluent. If the method of separation of the plasma intended for injectable products involves a system in which an airway must be inserted into the plasma container, the airway shall be sterile and constructed so as to exclude microorganisms and maintain a sterile system.
( b ) *Final containers.* Final containers used for Source Plasma, whether integrally attached or separated from the original blood container, shall not be entered prior to issuance for any purpose except for filling with the plasma. Such containers shall be uncolored and hermetically sealed, and shall permit clear visibility of the contents. Final containers and their components shall not interact with the plasma contents under conditions of storage and use so as to alter the safety, quality, purity, or potency of the plasma and shall provide adequate protection against external factors that may cause deterioration or contamination. Prior to filling, the final container shall be marked or identified by number or other symbol which will relate it directly to the donor.
( c ) *Preservative.* Source Plasma shall not contain a preservative.
[38 FR 32089, Nov. 20, 1973, as amended at 41 FR 10769, Mar. 12, 1976; 50 FR 4140, Jan. 29, 1985]
# L_2023105DE.01006801.xml

| 20.4.2023 | DE | Amtsblatt der Europäischen Union | L 105/68 |
| --- | --- | --- | --- |

20.4.2023

DE

Amtsblatt der Europäischen Union

L 105/68

---

Berichtigung der Verordnung (EU) 2019/4 des Europäischen Parlaments und des Rates vom 11. Dezember 2018 über die Herstellung, das Inverkehrbringen und die Verwendung von Arzneifuttermitteln, zur Änderung der Verordnung (EG) Nr. 183/2005 des Europäischen Parlaments und des Rates sowie zur Aufhebung der Richtlinie 90/167/EWG des Rates

(
  Amtsblatt der Europäischen Union L 4 vom 7. Januar 2019
  )

Seite 6, Artikel 2 Absatz 2:

Anstatt:

Anstatt:

„(2)   Diese Verordnung gilt nicht für Tierarzneimittel im Sinne der Verordnung (EU) 2019/6, es sei denn, sie werden in ein Arzneifuttermittel oder ein Zwischenerzeugnis eingemischt.“

muss es heißen:

muss es heißen:

„(2)   Diese Verordnung gilt nicht für Tierarzneimittel im Sinne der Verordnung (EU) 2019/6, es sei denn, sie sind in ein Arzneifuttermittel oder ein Zwischenerzeugnis eingemischt.“

---
Editorial Note on Part 870
Editorial Note: Nomenclature changes to part 870 appear at 73 FR 35341, June 23, 2008.

§ 870.5175 Septostomy catheter. ( a ) *Identification.* A septostomy catheter is a special balloon catheter that is used to create or enlarge the atrial septal defect found in the heart of certain infants.
( b ) *Classification.* Class II (performance standards).
# C_2014361EN.01002002.xml

| 13.10.2014 | EN | Official Journal of the European Union | C 361/20 |
| --- | --- | --- | --- |

13.10.2014

EN

Official Journal of the European Union

C 361/20

---

Action brought on 11 August 2014 — Othman v Council

(Case T-601/14)

2014/C 361/30

Language of the case: French

Parties

Parties

Applicant: Razan Othman (Damascus, Syria) (represented by: E. Ruchat and C. Cornet d'Elzius, lawyers)

Applicant:

Defendant: Council of the European Union

Defendant:

Form of order sought

Form of order sought

The applicant claims that the Court should:

| — | declare the applicant’s action admissible and well-founded; |
| --- | --- |

—

declare the applicant’s action admissible and well-founded;

| — | in consequence, annul Decision 2014/309/CFSP of 28 May 2014 and its subsequent implementing measures, insofar as they concern the applicant; |
| --- | --- |

—

in consequence, annul Decision 2014/309/CFSP of 28 May 2014 and its subsequent implementing measures, insofar as they concern the applicant;

| — | order the Council of the European Union to pay the costs of the proceedings. |
| --- | --- |

—

order the Council of the European Union to pay the costs of the proceedings.

Pleas in law and main arguments

Pleas in law and main arguments

In support of the action, the applicant relies on three pleas in law which are in essence identical or similar to those relied on in Case T-432/11 Makhlouf v Council
   (1).

Makhlouf

Council

1

---

(1)  OJ C 290, p. 13.

1

---
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Labor

###### Employee Benefits Security Administration

Pursuant to the authority contained in Section 512 of the Employee Retirement Income Security Act of 1974 (ERISA), 29 U.S.C. 1142, the 150th open meeting of the full Advisory Council on Employee Welfare and Pension Benefit Plans will be held on March 22, 2010.

The session will take place in Room S-2508, U.S. Department of Labor, 200 Constitution Avenue, NW., Washington, DC 20210. The purpose of the open meeting, which will run from 1:30 p.m. to approximately 4:30 p.m., is to introduce the Council Chair and Vice Chair, receive an update from the Assistant Secretary of Labor for the Employee Benefits Security Administration, and determine the topics to be addressed by the Council in 2010.

Organizations or members of the public wishing to submit a written statement may do so by submitting 30 copies on or before March 15, 2010 to Larry Good, Executive Secretary, ERISA Advisory Council, U.S. Department of Labor, Suite N-5623, 200 Constitution Avenue, NW., Washington, DC 20210. Statements received on or before March 15, 2010 will be included in the record of the meeting. Individuals or representatives of organizations wishing to address the Advisory Council should forward their requests to the Executive Secretary or telephone (202) 693-8668. Oral presentations will be limited to ten minutes, time permitting, but an extended statement may be submitted for the record. Individuals with disabilities who need special accommodations should contact Larry Good by March 15 at the address indicated.

      ( print page 11200)    
Signed at Washington, DC, this 22nd day of February, 2010.

Phyllis C. Borzi, 

Assistant Secretary, Employee Benefits Security Administration, United States Department of Labor.

[FR Doc. 2010-5137 Filed 3-5-10; 4:15 pm]

BILLING CODE 4510-29-P
# C_2015007EN.01005801.xml

| 12.1.2015 | EN | Official Journal of the European Union | C 7/58 |
| --- | --- | --- | --- |

12.1.2015

EN

Official Journal of the European Union

C 7/58

---

Action brought on 27 October 2014 — ZZ v Commission

(Case F-122/14)

(2015/C 007/74)

Language of the case: French

Parties

Parties

Applicant: ZZ (represented by: J.-N. Louis, R. Metz and D. Verbeke, lawyers)

Applicant:

Defendant: Commission

Defendant:

Subject-matter and description of the proceedings

Subject-matter and description of the proceedings

On one hand, the finding of the inapplicability of Regulation 1023/2013 of the Parliament and of the Council of 22 October 2013 amending the Staff Regulations of Officials of the European Union and the Conditions of Employment of Other Servants of the European Union in that it provides for the suspension of the method of adjusting remuneration and introduces a solidarity levy, and, on the other hand, the annulment of the decision of the Council applying that solidarity levy from 1 January 2014 to the applicant’s remuneration although his remuneration is not subject to adjustment for the period between 1 January 2014 and 30 June 2015.

Form of order sought

Form of order sought

| — | Declare the inapplicability of Regulation 1023/2013 in that it provides for the suspension from 1 July 2013 to 30 June 2015 of the method of adjusting remuneration set out in Annex XI to the Staff Regulations while reintroducing, for the same period, a collection of a ‘solidarity’ levy of 6 %; |
| --- | --- |

—

Declare the inapplicability of Regulation 1023/2013 in that it provides for the suspension from 1 July 2013 to 30 June 2015 of the method of adjusting remuneration set out in Annex XI to the Staff Regulations while reintroducing, for the same period, a collection of a ‘solidarity’ levy of 6 %;

| — | Consequently, annul the contested decision; |
| --- | --- |

—

Consequently, annul the contested decision;

| — | Order the Commission to pay the costs. |
| --- | --- |

—

Order the Commission to pay the costs.

---
I 

118TH CONGRESS 

2D SESSION H. R. 7955 

To increase penalties for child pornography. 

IN THE HOUSE OF REPRESENTATIVES 

APRIL 11, 2024 

Mrs. LUNA (for herself and Mrs. MILLER of Illinois) introduced the following 

bill; which was referred to the Committee on the Judiciary 

A BILL 

To increase penalties for child pornography. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Holding Child Preda5 tors Accountable Act’’. 

6 SEC. 2. POSSESSION OF CHILD PORN. 

7 (a) OBSCENITY.—Section 1466A of title 18, United 

8 States Code, is amended— 

9 (1) in subsection (a), by striking ‘‘shall be sub10 ject to the penalties provided in section 2252A(b)(1), 

11 including the penalties provided for cases involving 


ssavage on LAPJG3WLY3PROD with BILLS
2 

•HR 7955 IH

1 a prior conviction’’ and inserting ‘‘shall be fined and 

2 punished by death or imprisoned for life’’; and 

3 (2) in subsection (b), by striking ‘‘shall be sub4 ject to the penalties provided in section 2252A(b)(2), 

5 including the penalties provided for cases involving 

6 a prior conviction’’ and inserting ‘‘shall be fined and 

7 punished by death or imprisoned for life’’. 

8 (b) EXPLOITATION MATERIAL.—Subsection (b) of 

9 section 2252 of title 18, United States Code, is amended 

10 to read as follows: 

11 ‘‘(b) Whoever violates, or attempts or conspires to 

12 violate paragraph (1), (2), (3), or (4) of subsection (a) 

13 shall be fined and punished by death or imprisoned for 

14 life.’’. 

15 (c) PORNOGRAPHY MATERIAL.—Subsection (b) of 

16 section 2252A of title 18, United States Code, is amended 

17 to read as follows: 

18 ‘‘(b) Whoever violates, or attempts or conspires to 

19 violate paragraph (1), (2), (3), (4), (5), (6), or (7) of sub20 section (a) shall be fined and punished by death or impris21 oned for life.’’. 

Æ 


ssavage on LAPJG3WLY3PROD with BILLS
Editorial Note on Part 870
Editorial Note: Nomenclature changes to part 870 appear at 73 FR 35341, June 23, 2008.

§ 870.1310 Vessel dilator for percutaneous catheterization. ( a ) *Identification.* A vessel dilator for percutaneous catheterization is a device which is placed over the guide wire to enlarge the opening in the vessel, and which is then removed before sliding the catheter over the guide wire.
( b ) *Classification.* Class II (performance standards).
#### Theodore GRIFFIN, Appellant, v. George N. MARTIN, III, Warden; Attorney General of the State of S.C., Appellees.

No. 85-6581.

United States Court of Appeals, Fourth Circuit.

Argued June 2, 1986.

Decided July 10, 1986.

Steven H. Goldblatt, Director, Appellate Litigation Clinical Program, Georgetown University Law Center (Samuel Dash, Director, Martha J. Tomich, Appellate Law Fellow, Washington, D.C., Mary Rose Kornreich and Charles Kelly, Student Counsel, on brief), for appellant.

Donald J. Zelenka, Chief Deputy Atty. Gen. (T. Travis Medlock, Atty. Gen., Columbia, S.C., on brief), for appellees.

Before WINTER, Chief Judge, and RUSSELL, WIDENER, HALL, PHILLIPS, MURNAGHAN, SPROUSE, ERVIN, CHAPMAN, and WILKINSON, Circuit Judges, sitting *en banc.*

MURNAGHAN, Circuit Judge:

The judgment of the district court denying a writ of *habeas corpus*is affirmed by an equally divided vote of the Court. In light of the grant of rehearing *en banc,*the majority and dissenting opinions at the panel level are withdrawn.

AFFIRMED.
#### Robert C. Ransom, Plaintiff-Appellant, v. Dr. William G. Cummings, et al., Defendants-Appellees.

Gen. No. 68-143. (Abstract of Decision.)

Second District.

May 15, 1969.

Gatenbey, Spuller, Law and Johnson, of Chicago, for appellant; Whitman, Kauffman and Couri, of Winnetka, for appellee.

Opinion by

JUSTICE SEIDENFELD.

Not to be published in full.
IN THE SUPREME COURT OF PENNSYLVANIA

MIDDLE DISTRICT

AARON J. BRESSI,

Petitioner

v.

DEPARTMENT OF HUMAN SERVICES,

Respondent

:

:

:

:

:

:

:

:

:

:

:

No. 97 MM 2022

ORDER

PER CURIAM

AND NOW, this 10th day of February, 2023, the “Application for Appointment of 

Counsel to File Petition for Allowance of Appeal” is DENIED.
[Federal Register Volume 75, Number 46 (Wednesday, March 10, 2010)]
[Notices]
[Page 11180]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-5100]


-----------------------------------------------------------------------

FEDERAL MARITIME COMMISSION


Ocean Transportation Intermediary License Applicants

    Notice is hereby given that the following applicants have filed 
with the Federal Maritime Commission an application for license as a 
Non-Vessel-Operating Common Carrier and Ocean Freight Forwarder--Ocean 
Transportation Intermediary pursuant to section 19 of the Shipping Act 
of 1984 as amended (46 U.S.C. Chapter 409 and 46 CFR 515).
    Persons knowing of any reason why the following applicants should 
not receive a license are requested to contact the Office of 
Transportation Intermediaries, Federal Maritime Commission, Washington, 
DC 20573.

Non-Vessel-Operating Common Carrier--Ocean Transportation Intermediary

AA Cargo, 139 Mitchell Avenue, Suite 201, South San Francisco, CA 
94080., Officer: Arben Hodza, CEO, CFO, Secretary (Qualifying 
Individual).

Non-Vessel-Operating Common Carrier and Ocean Freight Forwarder 
Transportation Intermediary

Hafen Consolidators USA, LLC, 103-01 NW 108th Avenue, Suite 11, Miami, 
FL 33178., Officers: Andres E. Valdano, Vice President (Qualifying 
Individual). Jose R. Hoppe, President.

Ocean Freight Forwarder--Ocean Transportation Intermediary

Pacific Glory USA, Inc., 5673 Old Dixie Highway, Suite 102, Forest 
Park, GA 30297.Officer: Kil Ra, CEO (Qualifying Individual).

    Dated: March 5, 2010.
Rachel E. Dickon,
Assistant Secretary.
[FR Doc. 2010-5100 Filed 3-9-10; 8:45 am]
BILLING CODE 6730-01-P
<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-28-1997
<PERIOD-END>                               DEC-28-1997
<CASH>                                         339,000
<SECURITIES>                                         0
<RECEIVABLES>                                  895,000
<ALLOWANCES>                                   595,000
<INVENTORY>                                  2,105,000
<CURRENT-ASSETS>                             4,850,000
<PP&E>                                      85,329,000
<DEPRECIATION>                              25,789,000
<TOTAL-ASSETS>                              76,260,000
<CURRENT-LIABILITIES>                       16,492,000
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                       157,000
<OTHER-SE>                                  36,256,000
<TOTAL-LIABILITY-AND-EQUITY>                76,260,000
<SALES>                                    131,857,000
<TOTAL-REVENUES>                           132,203,000
<CGS>                                       40,668,000
<TOTAL-COSTS>                               76,837,000
<OTHER-EXPENSES>                           122,000,000
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                           1,137,000
<INCOME-PRETAX>                           (74,735,000)
<INCOME-TAX>                                 1,537,000
<INCOME-CONTINUING>                       (73,198,000)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                              (73,198,000)
<EPS-PRIMARY>                                   (4.78)
<EPS-DILUTED>                                   (4.78)


</TABLE>
Editorial Note on Part 886
Editorial Note: Nomenclature changes to part 886 appear at 73 FR 35341, June 23, 2008.

§ 886.1120 Ophthalmic camera. ( a ) *Identification.* An ophthalmic camera is an AC-powered device intended to take photographs of the eye and the surrounding area.
( b ) *Classification.* Class II (special controls). The device, when it is a photorefractor or a general-use ophthalmic camera, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 886.9.
[55 FR 48441, Nov. 20, 1990, as amended at 84 FR 71817, Dec. 30, 2019]
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Justice

###### Drug Enforcement Administration

                    By Notice dated September 14, 2009, and published in the                     **Federal Register**                     on September 18, 2009, (74 FR 47962), GE Healthcare, 3350 North Ridge Avenue, Arlington Heights, Illinois 60004-1412, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of Cocaine (9041), a basic class of controlled substance listed in schedule II.                

The company plans to manufacture a radioactive product used in diagnostic imaging in the diagnosis of Parkinson's Disease and for manufacture in bulk for investigational new drug (IND) submission and clinical trials.

                    No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of GE Healthcare to manufacture the listed basic class of controlled substance is consistent with the public interest at this time. DEA has investigated GE Healthcare to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33,                           ( print page 1814)                        the above named company is granted registration as a bulk manufacturer of the basic class of controlled substance listed.                

Dated: January 6, 2010.

Joseph T. Rannazzisi,

Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

[FR Doc. 2010-509 Filed 1-12-10; 8:45 am]

BILLING CODE 4410-09-P
Editorial Note on Part 880
Editorial Note: Nomenclature changes to part 880 appear at 73 FR 35341, June 23, 2008.

§ 880.6870 Dry-heat sterilizer. ( a ) *Identification.* A dry-heat sterilizer is a device that is intended for use by a health care provider to sterilize medical products by means of dry heat.
( b ) *Classification.* Class II (performance standards).